Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
SJ Kaar, S Natesan, R Mccutcheon, OD Howes - Neuropharmacology, 2020 - Elsevier
Antipsychotic drugs are central to the treatment of schizophrenia and other psychotic
disorders but are ineffective for some patients and associated with side-effects and …
disorders but are ineffective for some patients and associated with side-effects and …
[HTML][HTML] Schizophrenia: overview and treatment options
KR Patel, J Cherian, K Gohil… - Pharmacy and …, 2014 - ncbi.nlm.nih.gov
Schizophrenia: Overview and Treatment Options - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …
Antipsychotic drug efficacy correlates with the modulation of D1 rather than D2 receptor-expressing striatal projection neurons
Elevated dopamine transmission in psychosis is assumed to unbalance striatal output
through D1-and D2-receptor-expressing spiny-projection neurons (SPNs). Antipsychotic …
through D1-and D2-receptor-expressing spiny-projection neurons (SPNs). Antipsychotic …
Dopamine targeting drugs for the treatment of schizophrenia: past, present and future
Schizophrenia is a chronic and debilitating neuropsychiatric disorder affecting
approximately 1% of the world's population. This disease is associated with considerable …
approximately 1% of the world's population. This disease is associated with considerable …
Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
S Miyamoto, N Miyake, LF Jarskog… - Molecular …, 2012 - nature.com
Since the introduction of chlorpromazine and throughout the development of the new-
generation antipsychotic drugs (APDs) beginning with clozapine, the D 2 receptor has been …
generation antipsychotic drugs (APDs) beginning with clozapine, the D 2 receptor has been …
The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review
J Peuskens, L Pani, J Detraux, M De Hert - CNS drugs, 2014 - Springer
Since the 1970s, clinicians have increasingly become more familiar with hyperprolactinemia
(HPRL) as a common adverse effect of antipsychotic medication, which remains the …
(HPRL) as a common adverse effect of antipsychotic medication, which remains the …
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
OBJECTIVE: Since all antipsychotics block dopamine D2 receptors, the authors investigated
how well D2 receptor occupancy in vivo predicts clinical response, extrapyramidal side …
how well D2 receptor occupancy in vivo predicts clinical response, extrapyramidal side …
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
S Miyamoto, GE Duncan, CE Marx… - Molecular psychiatry, 2005 - nature.com
The treatment of schizophrenia has evolved over the past half century primarily in the
context of antipsychotic drug development. Although there has been significant progress …
context of antipsychotic drug development. Although there has been significant progress …
Atypical antipsychotics: mechanism of action
P Seeman - The Canadian Journal of Psychiatry, 2002 - journals.sagepub.com
Background: Al though the prin ci pal brain tar get that all an tipsy chotic drugs at tach to is
the do pamine D2 re cep tor, tra di tional or typi cal an tipsy chot ics, by at tach ing to it, in …
the do pamine D2 re cep tor, tra di tional or typi cal an tipsy chot ics, by at tach ing to it, in …
Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study
Summary Background The polymorphic CYP2D6 enzyme metabolises the antipsychotic
drugs risperidone and aripiprazole to their active metabolites, 9OH-risperidone and …
drugs risperidone and aripiprazole to their active metabolites, 9OH-risperidone and …